146 related articles for article (PubMed ID: 34110400)
1. Tracing the roots of CLPD-NK by TET2 and STAT3.
Herling M; Braun T
Blood; 2021 Jun; 137(23):3156-3158. PubMed ID: 34110400
[No Abstract] [Full Text] [Related]
2. Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.
Pastoret C; Desmots F; Drillet G; Le Gallou S; Boulland ML; Thannberger A; Doncker AV; Salaun V; Damaj GL; Veyrat-Masson R; Tournilhac O; Moignet A; Pangault C; Roussel M; Fest T; Lamy T
Blood; 2021 Jun; 137(23):3237-3250. PubMed ID: 33512451
[TBL] [Abstract][Full Text] [Related]
3. Concurrent STAT3, DNMT3A, and TET2 mutations in T-LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential.
Raess PW; Cascio MJ; Fan G; Press R; Druker BJ; Brewer D; Spurgeon SE
Am J Hematol; 2017 Jan; 92(1):E6-E8. PubMed ID: 27761930
[No Abstract] [Full Text] [Related]
4. Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias.
Olson TL; Cheon H; Xing JC; Olson KC; Paila U; Hamele CE; Neelamraju Y; Shemo BC; Schmachtenberg M; Sundararaman SK; Toro MF; Keller CA; Farber EA; Onengut-Gumuscu S; Garrett-Bakelman FE; Hardison RC; Feith DJ; Ratan A; Loughran TP
Blood; 2021 Aug; 138(8):662-673. PubMed ID: 33786584
[TBL] [Abstract][Full Text] [Related]
5. STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia.
Ishida F; Matsuda K; Sekiguchi N; Makishima H; Taira C; Momose K; Nishina S; Senoo N; Sakai H; Ito T; Kwong YL
Cancer Sci; 2014 Mar; 105(3):342-6. PubMed ID: 24350896
[TBL] [Abstract][Full Text] [Related]
6. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.
Jerez A; Clemente MJ; Makishima H; Koskela H; Leblanc F; Peng Ng K; Olson T; Przychodzen B; Afable M; Gomez-Segui I; Guinta K; Durkin L; Hsi ED; McGraw K; Zhang D; Wlodarski MW; Porkka K; Sekeres MA; List A; Mustjoki S; Loughran TP; Maciejewski JP
Blood; 2012 Oct; 120(15):3048-57. PubMed ID: 22859607
[TBL] [Abstract][Full Text] [Related]
7. Genomic landscape of T-large granular lymphocyte leukemia and chronic lymphoproliferative disorder of NK cells: a single institution experience.
Fei F; Stehr H; Zehnder JL
Leuk Lymphoma; 2023 Sep; 64(9):1536-1544. PubMed ID: 37330635
[TBL] [Abstract][Full Text] [Related]
8. Cell size variations of large granular lymphocyte leukemia: Implication of a small cell subtype of granular lymphocyte leukemia with STAT3 mutations.
Tanahashi T; Sekiguchi N; Matsuda K; Takezawa Y; Ito T; Kobayashi H; Ichikawa N; Nishina S; Senoo N; Sakai H; Nakazawa H; Ishida F
Leuk Res; 2016 Jun; 45():8-13. PubMed ID: 27064362
[TBL] [Abstract][Full Text] [Related]
9. [Large Granular Lymphocytic Leukemia and JAK/STAT Signaling Pathway--Review].
Qiu ZY; Fan Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):254-60. PubMed ID: 26913432
[TBL] [Abstract][Full Text] [Related]
10. STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells.
Kawakami T; Sekiguchi N; Kobayashi J; Yamane T; Nishina S; Sakai H; Hirabayashi Y; Nakazawa H; Ishida F
Int J Hematol; 2019 May; 109(5):563-571. PubMed ID: 30859397
[TBL] [Abstract][Full Text] [Related]
11. T cell large granular lymphocyte leukemia and chronic NK lymphocytosis.
Barilà G; Calabretto G; Teramo A; Vicenzetto C; Gasparini VR; Semenzato G; Zambello R
Best Pract Res Clin Haematol; 2019 Sep; 32(3):207-216. PubMed ID: 31585621
[TBL] [Abstract][Full Text] [Related]
12. Somatic STAT3 mutations in large granular lymphocytic leukemia.
Koskela HL; Eldfors S; Ellonen P; van Adrichem AJ; Kuusanmäki H; Andersson EI; Lagström S; Clemente MJ; Olson T; Jalkanen SE; Majumder MM; Almusa H; Edgren H; Lepistö M; Mattila P; Guinta K; Koistinen P; Kuittinen T; Penttinen K; Parsons A; Knowles J; Saarela J; Wennerberg K; Kallioniemi O; Porkka K; Loughran TP; Heckman CA; Maciejewski JP; Mustjoki S
N Engl J Med; 2012 May; 366(20):1905-13. PubMed ID: 22591296
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the signal transducer and activator of transcription family of genes in cancer.
Shahmarvand N; Nagy A; Shahryari J; Ohgami RS
Cancer Sci; 2018 Apr; 109(4):926-933. PubMed ID: 29417693
[TBL] [Abstract][Full Text] [Related]
14. Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations.
Rajala HL; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S
Ann Med; 2014 May; 46(3):114-22. PubMed ID: 24512550
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutations in
Gao LM; Zhao S; Zhang WY; Wang M; Li HF; Lizaso A; Liu WP
Cancer Biol Ther; 2019; 20(10):1319-1327. PubMed ID: 31311407
[TBL] [Abstract][Full Text] [Related]
16. Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia.
Huang L; Liu D; Wang N; Ling S; Tang Y; Wu J; Hao L; Luo H; Hu X; Sheng L; Zhu L; Wang D; Luo Y; Shang Z; Xiao M; Mao X; Zhou K; Cao L; Dong L; Zheng X; Sui P; He J; Mo S; Yan J; Ao Q; Qiu L; Zhou H; Liu Q; Zhang H; Li J; Jin J; Fu L; Zhao W; Chen J; Du X; Qing G; Liu H; Liu X; Huang G; Ma D; Zhou J; Wang QF
Cell Res; 2018 Feb; 28(2):172-186. PubMed ID: 29148541
[TBL] [Abstract][Full Text] [Related]
17. The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.
Rajala HL; Olson T; Clemente MJ; Lagström S; Ellonen P; Lundan T; Hamm DE; Zaman SA; Lopez Marti JM; Andersson EI; Jerez A; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S
Haematologica; 2015 Jan; 100(1):91-9. PubMed ID: 25281507
[TBL] [Abstract][Full Text] [Related]
18. STAT3 mutations are frequent in T-cell large granular lymphocytic leukemia with pure red cell aplasia.
Qiu ZY; Fan L; Wang L; Qiao C; Wu YJ; Zhou JF; Xu W; Li JY
J Hematol Oncol; 2013 Oct; 6():82. PubMed ID: 24283217
[TBL] [Abstract][Full Text] [Related]
19. Consequences of mutant TET2 on clonality and subclonal hierarchy.
Hirsch CM; Nazha A; Kneen K; Abazeed ME; Meggendorfer M; Przychodzen BP; Nadarajah N; Adema V; Nagata Y; Goyal A; Awada H; Asad MF; Visconte V; Guan Y; Sekeres MA; Olinski R; Jha BK; LaFramboise T; Radivoyevitch T; Haferlach T; Maciejewski JP
Leukemia; 2018 Aug; 32(8):1751-1761. PubMed ID: 29795413
[TBL] [Abstract][Full Text] [Related]
20. A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cells.
Gasparini VR; Binatti A; Coppe A; Teramo A; Vicenzetto C; Calabretto G; Barilà G; Barizza A; Giussani E; Facco M; Mustjoki S; Semenzato G; Zambello R; Bortoluzzi S
Blood Cancer J; 2020 Apr; 10(4):42. PubMed ID: 32321919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
